Amedeo Smart

Free Medical Literature Service


 

Amedeo

Influenza

  Free Subscription

20.05.2024

1 Arch Virol
1 Biochem Biophys Res Commun
3 BMC Pediatr
9 BMJ
1 Cell
1 Drugs
1 Epidemiol Infect
8 J Infect Dis
12 J Virol
3 JAMA
7 Lancet
3 N Engl J Med
2 PLoS Comput Biol
35 PLoS One
3 Proc Natl Acad Sci U S A
8 Vaccine
3 Virology



    Arch Virol

  1. ASADIPOOYA K, Asadipooya A, Adatorwovor R
    Combination of spironolactone and DPP-4 inhibitors for treatment of SARS-CoV-2 infection: a literature review.
    Arch Virol. 2024;169:122.
    >> Share


    Biochem Biophys Res Commun

  2. KULMA M, Sakanovic A, Bedina-Zavec A, Caserman S, et al
    Sequestration of membrane cholesterol by cholesterol-binding proteins inhibits SARS-CoV-2 entry into Vero E6 cells.
    Biochem Biophys Res Commun. 2024;716:149954.
    >> Share


    BMC Pediatr

  3. AL-IEDE M, Alhouri A, Marwa K, Alnajjar R, et al
    Respiratory syncytial virus in pediatric patients admitted to a tertiary center in Amman: clinical characteristics, and age-related patterns.
    BMC Pediatr. 2024;24:334.
    >> Share

  4. JIANG Z, Fang C, Peng F, Fan W, et al
    Comparison of clinical characteristics and disease burden of febrile seizures in children with and without COVID-19.
    BMC Pediatr. 2024;24:329.
    >> Share

  5. HUANG L, Ye C, Zhou R, Ji Z, et al
    Diagnostic value of routine blood tests in differentiating between SARS-CoV-2, influenza A, and RSV infections in hospitalized children: a retrospective study.
    BMC Pediatr. 2024;24:328.
    >> Share


    BMJ

  6. WISE J
    Sixty seconds on . . . the pandemic treaty.
    BMJ. 2024;385:q1124.
    >> Share

  7. MAHASE E
    Hospitals are urged to increase use of virtual wards to cut admissions.
    BMJ. 2024;385:q1123.
    >> Share

  8. NOGRADY B
    Australia: Inductions and preterm births fell during early pandemic years.
    BMJ. 2024;385:q1112.
    >> Share


  9. Seven days in medicine: 8-14 May 2024.
    BMJ. 2024;385:q1079.
    >> Share

  10. LANG K
    What do we know about covid-19's effects on the brain?
    BMJ. 2024;385:q897.
    >> Share

  11. NAKWEYA G
    Doctors in Kenya end strike after threat of court action.
    BMJ. 2024;385:q1088.
    >> Share

  12. MAHASE E
    Infective endocarditis: Coroner's report questions NICE guidance on prevention.
    BMJ. 2024;385:q1081.
    >> Share

  13. O'CONNOR RJ, Parkin A, Mir G, Mullard J, et al
    Work and vocational rehabilitation for people living with long covid.
    BMJ. 2024;385:e076508.
    >> Share

  14. LOOI MK
    Sixty seconds on . . . Apple Watch.
    BMJ. 2024;385:q1063.
    >> Share


    Cell

  15. HARTMANN JA, Cardoso MR, Talarico MCR, Kenney DJ, et al
    Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses.
    Cell. 2024;187:2393-2410.
    >> Share


    Drugs

  16. ZHU C, Pang S, Liu J, Duan Q, et al
    Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines.
    Drugs. 2024;84:403-423.
    >> Share


    Epidemiol Infect

  17. PARK JO, Cho HK, Jeon CH, Kim SH, et al
    Characteristics and biomarkers associated with mortality in COVID-19 patients presenting to the emergency department.
    Epidemiol Infect. 2024;152:e76.
    >> Share


    J Infect Dis

  18. MOTSOENENG BM, Dhar N, Nunes MC, Krammer F, et al
    Hemagglutinin stalk-specific Fc-mediated functions are associated with protection against influenza-illness after seasonal influenza vaccination in pregnant women.
    J Infect Dis. 2024 May 14:jiae241. doi: 10.1093.
    >> Share

  19. BEN MAMOUN C, Vydyam P
    Response to the Letter by Liu and Colleagues.
    J Infect Dis. 2024;229:1601.
    >> Share

  20. FOTOOH ABADI L, Sharma MB, Kelesidis T
    Single-Cell Profiling of the Differential In Vivo Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Lung Tissue Cell Subtypes at the Protein Level.
    J Infect Dis. 2024;229:1382-1386.
    >> Share

  21. WONG M, Gain C, Sharma MB, Fotooh Abadi L, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Infection Alters Mediators of Lung Tissue Remodeling In Vitro and In Vivo.
    J Infect Dis. 2024;229:1372-1381.
    >> Share

  22. KARABA AH, Morgenlander WR, Johnston TS, Hage C, et al
    Epitope Mapping of SARS-CoV-2 Spike Antibodies in Vaccinated Kidney Transplant Recipients Reveals Poor Spike Coverage Compared to Healthy Controls.
    J Infect Dis. 2023 Nov 29:jiad534. doi: 10.1093.
    >> Share

  23. DOS RAMOS ALMEIDA CJL, Veras FP, Paiva IM, Schneider AH, et al
    Neutrophil Virucidal Activity Against SARS-CoV-2 Is Mediated by Neutrophil Extracellular Traps.
    J Infect Dis. 2024;229:1352-1365.
    >> Share

  24. LEDUCQ V, Zafilaza K, Fauchois A, Ghidaoui E, et al
    Spike Protein Genetic Evolution in Patients at High Risk of Severe Coronavirus Disease 2019 Treated by Monoclonal Antibodies.
    J Infect Dis. 2024;229:1341-1351.
    >> Share

  25. HAIDAR G, Hodges JC, Bilderback A, Lukanski A, et al
    Prospective assessment of humoral and cellular immune responses to a 3rd COVID-19 mRNA vaccine dose among immunocompromised individuals.
    J Infect Dis. 2023 Nov 16:jiad511. doi: 10.1093.
    >> Share


    J Virol

  26. MEADE PS, Bandawane P, Bushfield K, Hoxie I, et al
    Detection of clade 2.3.4.4b highly pathogenic H5N1 influenza virus in New York City.
    J Virol. 2024 May 15:e0062624. doi: 10.1128/jvi.00626.
    >> Share

  27. VIOX EG, Bosinger SE, Douek DC, Schreiber G, et al
    Harnessing the power of IFN for therapeutic approaches to COVID-19.
    J Virol. 2024 Apr 23:e0120423. doi: 10.1128/jvi.01204.
    >> Share

  28. MAO D, Liu S, Phan AT, Renner S, et al
    The TRAF3-DYRK1A-RAD54L2 complex maintains ACE2 expression to promote SARS-CoV-2 infection.
    J Virol. 2024 Apr 23:e0034724. doi: 10.1128/jvi.00347.
    >> Share

  29. HAN Y, Yuan Z, Yi Z
    Identification of a membrane-associated element (MAE) in the C-terminal region of SARS-CoV-2 nsp6 that is essential for viral replication.
    J Virol. 2024 Apr 19:e0034924. doi: 10.1128/jvi.00349.
    >> Share

  30. PEREZ DR
    A devastating blow: personal reflections on Argentina's scientific decline.
    J Virol. 2024 Apr 16:e0054924. doi: 10.1128/jvi.00549.
    >> Share

  31. ISHIMARU H, Nishimura M, Shigematsu H, Marini MI, et al
    Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a conserved subdomain 1 of the spike protein.
    J Virol. 2024 Apr 16:e0041624. doi: 10.1128/jvi.00416.
    >> Share

  32. TAKADA K, Orba Y, Kida Y, Wu J, et al
    Genes involved in the limited spread of SARS-CoV-2 in the lower respiratory airways of hamsters may be associated with adaptive evolution.
    J Virol. 2024 Apr 16:e0178423. doi: 10.1128/jvi.01784.
    >> Share

  33. BOON ACM, Bricker TL, Fritch EJ, Leist SR, et al
    Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19.
    J Virol. 2024 Apr 9:e0190323. doi: 10.1128/jvi.01903.
    >> Share

  34. YANG R, Han P, Han P, Li D, et al
    Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2.
    J Virol. 2024 Apr 9:e0045124. doi: 10.1128/jvi.00451.
    >> Share

  35. XIAO X, Fu Y, You W, Huang C, et al
    Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
    J Virol. 2024 Apr 4:e0157323. doi: 10.1128/jvi.01573.
    >> Share

  36. BRUNET J, Choucha Z, Gransagne M, Tabbal H, et al
    A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.
    J Virol. 2024 Apr 2:e0169323. doi: 10.1128/jvi.01693.
    >> Share

  37. NAMBULLI S, Escriou N, Rennick LJ, Demers MJ, et al
    A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.
    J Virol. 2024 Apr 2:e0176223. doi: 10.1128/jvi.01762.
    >> Share


    JAMA

  38. XIE Y, Choi T, Al-Aly Z
    Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024.
    JAMA. 2024 May 15:e247395. doi: 10.1001/jama.2024.7395.
    >> Share


  39. Audio Highlights.
    JAMA. 2024;331:e2318283.
    >> Share

  40. CHESHIRE WP, Dudenkov DV, Munipalli B
    Tilt Table Testing.
    JAMA. 2024;331:1494-1495.
    >> Share


    Lancet

  41. KOJIMA N, Adlhoch C, Mitja O, Dat VQ, et al
    Building global preparedness for avian influenza.
    Lancet. 2024 May 9:S0140-6736(24)00934-6. doi: 10.1016/S0140-6736(24)00934.
    >> Share

  42. WATTS G
    Alasdair Macintosh Geddes.
    Lancet. 2024;403:1846.
    >> Share

  43. AUJLA M
    Art, plunder, fragile fault lines.
    Lancet. 2024;403:1844-1845.
    >> Share

  44. USHER AD
    Organisations vie for control over pandemic financing.
    Lancet. 2024;403:1839-1840.
    >> Share

  45. GREENHALGH T, MacIntyre CR, Ungrin M, Wright JM, et al
    Airborne pathogens: controlling words won't control transmission.
    Lancet. 2024;403:1850-1851.
    >> Share

  46. YANG YT
    Protecting humanitarian aid workers: an urgent call.
    Lancet. 2024;403:1847.
    >> Share

  47. ABUZERR S, Zinser K
    Amplifying the voices of women in the Gaza Strip.
    Lancet. 2024;403:1848-1849.
    >> Share


    N Engl J Med

  48. HERBERT C, McManus DD, Soni A
    False Positive Covid-19 Rapid Antigen Tests. Reply.
    N Engl J Med. 2024;390:1836.
    >> Share

  49. YANG C, Espin E, Tebbutt SJ
    False Positive Covid-19 Rapid Antigen Tests.
    N Engl J Med. 2024;390:1835-1836.
    >> Share

  50. SCHUBACH A, Ricotta D, Kittleson MM
    To Preround or Not to Preround.
    N Engl J Med. 2024;390:1824-1826.
    >> Share


    PLoS Comput Biol

  51. LOPEZ VK, Cramer EY, Pagano R, Drake JM, et al
    Challenges of COVID-19 Case Forecasting in the US, 2020-2021.
    PLoS Comput Biol. 2024;20:e1011200.
    >> Share

  52. ASPLIN P, Keeling MJ, Mancy R, Hill EM, et al
    Epidemiological and health economic implications of symptom propagation in respiratory pathogens: A mathematical modelling investigation.
    PLoS Comput Biol. 2024;20:e1012096.
    >> Share


    PLoS One

  53. BRETANA NA, Kwon JA, Grant L, Galouzis J, et al
    Controlling COVID-19 outbreaks in the correctional setting: A mathematical modelling study.
    PLoS One. 2024;19:e0303062.
    >> Share

  54. SHERAK RAG, Sajjadi H, Khimani N, Tolchin B, et al
    SOFA score performs worse than age for predicting mortality in patients with COVID-19.
    PLoS One. 2024;19:e0301013.
    >> Share

  55. THAMPI N, Burhunduli T, Strain J, Raudanskis A, et al
    Detection of SARS-CoV-2 in schools using built environment testing in Ottawa, Canada: A multi-facility prospective surveillance study.
    PLoS One. 2024;19:e0300397.
    >> Share

  56. HARRIS J, Germain J, McCoy E, Schofield R, et al
    Ethical guidance for conducting health research with online communities: A scoping review of existing guidance.
    PLoS One. 2024;19:e0302924.
    >> Share

  57. FENG W, Zhao L, Ge Z, Zhao X, et al
    Association between physical activity and adolescent mental health in the post COVID-19: The chain mediating effect of self-esteem and social anxiety.
    PLoS One. 2024;19:e0301617.
    >> Share

  58. ESPOSITO G, Hunashal Y, Percipalle M, Fogolari F, et al
    Assessing nanobody interaction with SARS-CoV-2 Nsp9.
    PLoS One. 2024;19:e0303839.
    >> Share

  59. GUNAY-POLATKAN S, Caliskan S, Sigirli D
    Association of atherogenic indices with myocardial damage and mortality in COVID-19.
    PLoS One. 2024;19:e0302984.
    >> Share

  60. PANAHI R, Ghorbanpour Z, Moradi B, Eidy F, et al
    The relationship between health literacy and the adoption of COVID-19 preventive behaviors: A cross-sectional study in Iran.
    PLoS One. 2024;19:e0299007.
    >> Share

  61. UMEH GC, Cleenwerck de Kiev L, Mamza J, Atiku A, et al
    Symptoms of depression among outpatients with suspected COVID-19 in metropolitan Local Government Areas of Kaduna State, Nigeria.
    PLoS One. 2024;19:e0288567.
    >> Share

  62. URAZAYEVA ST, Kurmangaliyeva SS, Kaliyev AA, Tussupkaliyeva KS, et al
    Attitude toward vaccination against COVID-19 and acceptance of the national "QazVac" vaccine in the Aktobe city population, West Kazakhstan: A cross-sectional survey.
    PLoS One. 2024;19:e0303854.
    >> Share

  63. ZHOU Q, Zhao G, Pan Y, Zhang Y, et al
    The efficacy and safety of fluvoxamine in patients with COVID-19: A systematic review and meta-analysis from randomized controlled trials.
    PLoS One. 2024;19:e0300512.
    >> Share

  64. SHYU D, Bliss P, Adams A, Cho RJ, et al
    Development and performance evaluation of a solenoid valve assisted low-cost ventilator on gas exchange and respiratory mechanics in a porcine model.
    PLoS One. 2024;19:e0303443.
    >> Share

  65. DUNCAN G, Christensen WF, Handley C
    COVID-19 hotspot detection in a university setting.
    PLoS One. 2024;19:e0289254.
    >> Share

  66. OLIVEIRA ES, Nascimento ALBD, Ferreira Junior WS, Albuquerque UP, et al
    How does prestige bias affect information recall during a pandemic?
    PLoS One. 2024;19:e0303512.
    >> Share

  67. KHALIL B, Sharif-Askari NS, Hafezi S, Sharif-Askari FS, et al
    Vitamin D regulates COVID-19 associated severity by suppressing the NLRP3 inflammasome pathway.
    PLoS One. 2024;19:e0302818.
    >> Share

  68. KASPERSKA A, Matysiak A, Cukrowska-Torzewska E
    Managerial (dis)preferences towards employees working from home: Post-pandemic experimental evidence.
    PLoS One. 2024;19:e0303307.
    >> Share

  69. PARK J, Joo H, Kim D, Mase S, et al
    Cost-effectiveness of mask mandates on subways to prevent SARS-CoV-2 transmission in the United States.
    PLoS One. 2024;19:e0302199.
    >> Share

  70. BISHOP-EDWARDS L, Taylor Buck E, Weich S
    The delivery of creative socially prescribed activities for people with serious mental health needs during lockdown: Learning about remote, digital and hybrid delivery.
    PLoS One. 2024;19:e0301550.
    >> Share

  71. BABAR M, Qureshi B, Koubaa A
    Investigating the impact of data heterogeneity on the performance of federated learning algorithm using medical imaging.
    PLoS One. 2024;19:e0302539.
    >> Share

  72. HUNTER PR, Brainard J
    Changing risk factors for developing SARS-CoV-2 infection from Delta to Omicron.
    PLoS One. 2024;19:e0299714.
    >> Share

  73. ARGENIO KL, Day SE, D'Agostino EM, Neshteruk C, et al
    Increasing disparities in obesity and severe obesity prevalence among public elementary and middle school students in New York City, school years 2011-12 through 2019-20.
    PLoS One. 2024;19:e0302099.
    >> Share

  74. XU W, Bao X, Lou X, Liu X, et al
    Feature fusion method for pulmonary tuberculosis patient detection based on cough sound.
    PLoS One. 2024;19:e0302651.
    >> Share

  75. KHEZRI M, McKnight C, Weng CA, Kimball S, et al
    COVID-19 vaccination uptake and determinants of booster vaccination among persons who inject drugs in New York City.
    PLoS One. 2024;19:e0303394.
    >> Share

  76. YANG Q, Chang A, Tong X, Jackson SL, et al
    Long-term cardiovascular disease outcomes in non-hospitalized medicare beneficiaries diagnosed with COVID-19: Population-based matched cohort study.
    PLoS One. 2024;19:e0302593.
    >> Share

  77. NHACOLO A, Magaco A, Amosse F, Hunguana A, et al
    Perceptions and compliance with COVID-19 preventive measures in Southern and Central regions of Mozambique: A quantitative in-person household survey in the districts of Manhica and Quelimane.
    PLoS One. 2024;19:e0278439.
    >> Share

  78. WANG B, Tong C, Chen T, Yang J, et al
    Evaluation of China's live streaming e-commerce industry policies based on a three-dimensional analysis framework.
    PLoS One. 2024;19:e0301451.
    >> Share

  79. WASSIE GT, Ambelie YA, Adebabay T, Yeshiwas AG, et al
    Covid-19 vaccine uptake and its associated factors among adult population in Dangila district, Awi Zone, Northwest Ethiopia: A mixed method study.
    PLoS One. 2024;19:e0302531.
    >> Share

  80. MEYER D, Lowensen K, Perrin N, Moore A, et al
    An evaluation of the impact of social and structural determinants of health on forgone care during the COVID-19 pandemic in Baltimore, Maryland.
    PLoS One. 2024;19:e0302064.
    >> Share

  81. FUKUYAMA K, Mori Y, Ueshima H, Ito S, et al
    Medical resource usage for COVID-19 evaluated using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
    PLoS One. 2024;19:e0303493.
    >> Share

  82. YASEEN A, DeSantis SM, Sabharwal R, Talebi Y, et al
    Baseline characteristics of SARS-CoV-2 vaccine non-responders in a large population-based sample.
    PLoS One. 2024;19:e0303420.
    >> Share

  83. GAO Y, Ma Y, Li Y, Zhao Y, et al
    Prevalence and correlates of mental disorders among Chinese overseas students during the COVID-19: A multi-regional cross-sectional analysis.
    PLoS One. 2024;19:e0303283.
    >> Share

  84. THOMAZELLI LM, Pinho JRR, Dorlass EG, Ometto T, et al
    Evidence of reassortment of avian influenza A (H2) viruses in Brazilian shorebirds.
    PLoS One. 2024;19:e0300862.
    >> Share

  85. BROWN RT, Zamora K, Rizzo A, Spar MJ, et al
    Improving measurement of functional status among older adults in primary care: A pilot study.
    PLoS One. 2024;19:e0303402.
    >> Share

  86. RYS M, Schollaert E, Van Hoye G
    Living the employer brand during a crisis? A qualitative study on internal employer branding in times of the COVID-19 pandemic.
    PLoS One. 2024;19:e0303361.
    >> Share

  87. SIMONSSON O, Fisher SD
    Mindfulness meditation use in Britain during the COVID-19 pandemic.
    PLoS One. 2024;19:e0303349.
    >> Share


    Proc Natl Acad Sci U S A

  88. OTTER CJ, Renner DM, Fausto A, Tan LH, et al
    Interferon signaling in the nasal epithelium distinguishes among lethal and common cold coronaviruses and mediates viral clearance.
    Proc Natl Acad Sci U S A. 2024;121:e2402540121.
    >> Share

  89. KITAMURA S, Lin TH, Lee CD, Takamura A, et al
    Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry.
    Proc Natl Acad Sci U S A. 2024;121:e2310677121.
    >> Share

  90. XIE Y, Yang F, Huang J, He Y, et al
    Declining Chinese attitudes toward the United States amid COVID-19.
    Proc Natl Acad Sci U S A. 2024;121:e2322920121.
    >> Share


    Vaccine

  91. CARNALLA M, Stern D, Arantxa Colchero M, Rangel-Moreno K, et al
    Who is getting COVID-19 boosters? A latent class analysis in a nationally representative sample of Mexican adults 60 years and over.
    Vaccine. 2024;42:3273-3276.
    >> Share

  92. LIEVRE G, Sicsic J, Galmiche S, Charmet T, et al
    Are the 7C psychological antecedents associated with COVID-19 vaccine behaviours beyond intentions? A cross-sectional study on at-least-one-dose and up-to-date vaccination status, and uptake speed among adults in France.
    Vaccine. 2024 Apr 19:S0264-410X(24)00438-9. doi: 10.1016/j.vaccine.2024.
    >> Share

  93. RAMOS-DUARTE VA, Orlowski A, Jaquenod de Giusti C, Corigliano MG, et al
    Safe plant Hsp90 adjuvants elicit an effective immune response against SARS-CoV2-derived RBD antigen.
    Vaccine. 2024;42:3355-3364.
    >> Share

  94. MELNIKOW J, Padovani A, Zhang J, Miller M, et al
    Patient concerns and physician strategies for addressing COVID-19 vaccine hesitancy.
    Vaccine. 2024 Apr 15:S0264-410X(24)00437-7. doi: 10.1016/j.vaccine.2024.
    >> Share

  95. WONG IOL, Wong C, Mak N, Dai A, et al
    Assessment of the impact of the vaccine pass policy on COVID-19 vaccine hesitancy and uptake among Chinese adults in Hong Kong.
    Vaccine. 2024 Apr 15:S0264-410X(24)00449-3. doi: 10.1016/j.vaccine.2024.
    >> Share

  96. SUKIK L, Chemaitelly H, Ayoub HH, Coyle P, et al
    Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient.
    Vaccine. 2024 Apr 13:S0264-410X(24)00440-7. doi: 10.1016/j.vaccine.2024.
    >> Share

  97. LEE JS, Choi H, Shin SH, Hwang MJ, et al
    Characterization of Brighton Collaboration criteria for myocarditis and pericarditis following COVID-19 vaccine in Korean adolescents.
    Vaccine. 2024 Apr 11:S0264-410X(24)00446-8. doi: 10.1016/j.vaccine.2024.
    >> Share

  98. THAI H, Audet EC, Koestner R
    Motivation for COVID-19 Vaccination: Applying a Self-Determination Theory Perspective to a Global Health Crisis.
    Vaccine. 2024 Apr 9:S0264-410X(24)00439-0. doi: 10.1016/j.vaccine.2024.
    >> Share


    Virology

  99. LEE J, Naoe Y, Bang U, Nakagama Y, et al
    Neutralization sensitivity of SARS-CoV-2 Omicron variants FL.1 and GE.1 by therapeutic antibodies and XBB sera.
    Virology. 2024;595:110067.
    >> Share

  100. GILLOT C, Tre-Hardy M, Cupaiolo R, Blairon L, et al
    Assessment of the neutralizing antibody response in Omicron breakthrough cases in healthcare workers who received the homologous booster of Moderna mRNA-1273.
    Virology. 2024;595:110082.
    >> Share

  101. UENO S, Amarbayasgalan S, Sugiura Y, Takahashi T, et al
    Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication.
    Virology. 2024;595:110068.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016